Search results for "EPS"

showing 10 items of 1777 documents

Bilateral ruptures of the extensor mechanism of the knee: A systematic review

2017

Abstract Introduction We conduct a systematic and qualitative review of the current literature to evaluate studies that described bilateral ruptures of the extensor mechanism of the knee. Methods A comprehensive literature search was performed to evaluate all studies included in the literature until September 2016. Results Fourteen studies with a total of 44 patients met the inclusion criteria. There were 14 patients with CRF (61%), 6 patients were affected by diabetes mellitus (14%) while other 6 patients were obese patients (14%). Conclusion CRF represents the most frequent comorbidity in patients with bilateral quadriceps/patellar tendon ruptures.

030222 orthopedicsmedicine.medical_specialtybusiness.industryExtensor mechanismtendons rupture bilateral knee rupture tendons rupture quadriceps rupture CRF patellar tendon rupture030229 sport sciencesmusculoskeletal systemmedicine.diseaseComorbidityPatellar tendonArticleSurgery03 medical and health sciences0302 clinical medicineQuadriceps tendon ruptureDiabetes mellitusMedicineOrthopedics and Sports MedicineIn patientbusinessPatellar tendon rupture
researchProduct

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

2012

International audience; Chemotherapeutic agents are widely used for cancer treatment. In addition to their direct cytotoxic effects, these agents harness the host's immune system, which contributes to their antitumor activity. Here we show that two clinically used chemotherapeutic agents, gemcitabine (Gem) and 5-fluorouracil (5FU), activate the NOD-like receptor family, pyrin domain containing-3 protein (Nlrp3)-dependent caspase-1 activation complex (termed the inflammasome) in myeloid-derived suppressor cells (MDSCs), leading to production of interleukin-1β (IL-1β), which curtails anticancer immunity. Chemotherapy-triggered IL-1β secretion relied on lysosomal permeabilization and the relea…

0303 health sciencesCell growthmedicine.drug_classInflammasomeGeneral MedicineBiologyReceptor antagonistGeneral Biochemistry Genetics and Molecular BiologyCathepsin B3. Good health[SPI.AUTO]Engineering Sciences [physics]/Automatic03 medical and health sciences0302 clinical medicineImmune system[ SPI.AUTO ] Engineering Sciences [physics]/AutomaticImmunologymedicineMyeloid-derived Suppressor CellCancer researchCytotoxic T cellSecretion030304 developmental biology030215 immunologymedicine.drug
researchProduct

Correction: The landscape of epilepsy-related GATOR1 variants

2019

International audience; The original version of this article contained an error in the spelling of the author Erik H. Niks, which was incorrectly given as Erik Niks. This has now been corrected in both the PDF and HTML versions of the article.

0303 health sciencesbusiness.industryPublished ErratumMEDLINEmedicine.diseasecomputer.software_genreSpelling03 medical and health sciencesEpilepsy0302 clinical medicine[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticsmedicineArtificial intelligencebusinessPsychologycomputer030217 neurology & neurosurgeryGenetics (clinical)Natural language processing030304 developmental biology
researchProduct

Did you hear? Auditory prospective memory cues are more beneficial for autistic than for non-autistic children and adolescents

2021

Item does not contain fulltext Background: The transition from primary to secondary school is particularly difficult for autistic children, a transition underpinned by an increase in prospective memory (PM) demands. Aims: To better understand PM in autistic children of the relevant age range and its underlying processes, the current study investigated the impact of cue salience (distinctiveness) on PM in autistic and non-autistic children and adolescents. The study was unique in manipulating the visual and auditory salience of PM cues. Salient cues are assumed to put lower demands on executive control resources as compared to cues that blend in with the ongoing activity. Methods and procedu…

030506 rehabilitationmedicine.medical_specialtyAdolescentSensory processingInformationSystems_INFORMATIONINTERFACESANDPRESENTATION(e.g.HCI)Memory Episodicmedicine.medical_treatmentComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISIONAudiologyExecutive Function03 medical and health sciencesCognitionProspective memoryDevelopmental and Educational PsychologymedicineHumans0501 psychology and cognitive sciencesAutistic DisorderChildNeuro- en revalidatiepsychologieSalience (language)05 social sciencesNeuropsychology and rehabilitation psychologymedicine.diseaseClinical PsychologyAutismOptimal distinctiveness theoryCues0305 other medical sciencePsychology050104 developmental & child psychology
researchProduct

Assessment of genetically modified sugar beet H7‐1 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐006)

2017

Efsa Panel On Genetically Modified Organisms (gmo)Scientific opinionRequestor: European Commission (DG SANTE)Question number: EFSA-Q-2017-00026; Following the submission of application EFSA-GMO-RX-006 under Regulation (EC) No 1829/2003 fromKWS SAAT SE and Monsanto Company, the Panel on Genetically Modified Organisms of the EuropeanFood Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the datasubmitted in the context of the renewal of authorisation application for the herbicide-tolerantgenetically modified sugar beet H7-1. The data received in the context of this renewal applicationcontained a systematic search and evaluation of literature, updated bioinforma…

040301 veterinary sciencesVeterinary (miscellaneous)gmo[SDV]Life Sciences [q-bio]sugarbeetogmPlant Science010501 environmental sciencessugar beet;H7-1;renewal;articles 11 and 23;regulation (EC) No 1829/2003;CP4 EPSPS01 natural sciencesMicrobiology0403 veterinary sciencearticles 11 and 230105 earth and related environmental sciencesrenewalCP4 EPSPSfungiregulation (EC) No 1829/200304 agricultural and veterinary sciencessugar beet10079 Institute of Veterinary Pharmacology and Toxicologybetterave sucrièreH7‐1H7-1Scientific Opinion570 Life sciences; biologyAnimal Science and ZoologyParasitologyregulation (EC) No 1829/2003Food Science
researchProduct

Anthropoid versus strepsirhine status of the African Eocene primates Algeripithecus and Azibius: craniodental evidence.

2009

Recent fossil discoveries have demonstrated that Africa and Asia were epicentres for the origin and/or early diversification of the major living primate lineages, including both anthropoids (monkeys, apes and humans) and crown strepsirhine primates (lemurs, lorises and galagos). Competing hypotheses favouring either an African or Asian origin for anthropoids rank among the most hotly contested issues in paleoprimatology. The Afrocentric model for anthropoid origins rests heavily on the >45 Myr old fossil Algeripithecus minutus from Algeria, which is widely acknowledged to be one of the oldest known anthropoids. However, the phylogenetic position of Algeripithecus with respect to other p…

10207 Department of Anthropology010506 paleontologyAzibiusZoologyLemuractivity pattern1100 General Agricultural and Biological Sciences01 natural sciencesGeneral Biochemistry Genetics and Molecular Biology2300 General Environmental ScienceNocturnality03 medical and health sciencesSpecies Specificity1300 General Biochemistry Genetics and Molecular BiologyResearch articles2400 General Immunology and Microbiologybiology.animalAnimalsOdontometryPrimateCladePhylogenyprimate evolution030304 developmental biology0105 earth and related environmental sciencesGeneral Environmental Science[ SDU.STU.PG ] Sciences of the Universe [physics]/Earth Sciences/Paleontology0303 health sciencesGeneral Immunology and Microbiologybiology300 Social sciences sociology & anthropologyFossilsAlgeripithecus[SDV.BID.EVO]Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE]StrepsirhiniHaplorhiniGeneral Medicinebiology.organism_classificationStrepsirhini[ SDV.BID.EVO ] Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE]toothcombed primatesToothcombAlgeriaAfricaGeneral Agricultural and Biological Sciences[SDU.STU.PG]Sciences of the Universe [physics]/Earth Sciences/PaleontologyTooth
researchProduct

Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies

2016

Objective: To test previous signals of a risk of orofacial cleft (OC) and clubfoot with exposure to the antiepileptic lamotrigine, and to investigate risk of other congenital anomalies (CA).Methods: This was a population-based case–malformed control study based on 21 EUROCAT CA registries covering 10.1 million births (1995–2011), including births to 2005 in which the clubfoot signal was generated and a subsequent independent study population of 6.3 million births. A total of 226,806 babies with CA included livebirths, stillbirths, and terminations of pregnancy following prenatal diagnosis. First-trimester lamotrigine monotherapy exposure in OC cases and clubfoot cases was compared to other …

115congenital anomalies ; orofacial clefts ; lamotrigine ; pregnancy0302 clinical medicinePregnancyOdds RatioRegistries030212 general & internal medicineEPILEPSYeducation.field_of_studyTriazinesObstetricsAbsolute risk reductionANTIEPILEPTIC DRUGSAbnormalities Drug-InducedCleft PalateEuropeAnesthesiaINCREASED FREQUENCYAnticonvulsantsFemalemedicine.drugAdultRisk61medicine.medical_specialtyCleft LipPopulationPrenatal diagnosisLamotrigineLamotrigineSensitivity and SpecificityArticle03 medical and health sciencesJournal ArticlemedicineHumansAbnormalities Drug-Induced/epidemiology; Adult; Anticonvulsants/adverse effects; Anticonvulsants/therapeutic use; Case-Control Studies; Cleft Lip/chemically induced; Cleft Lip/epidemiology; Cleft Palate/chemically induced; Cleft Palate/epidemiology; Epilepsy/drug therapy; Epilepsy/epidemiology; Europe/epidemiology; Female; Humans; Odds Ratio; Pregnancy; Pregnancy Complications/drug therapy; Pregnancy Complications/epidemiology; Pregnancy Trimester First; Registries; Risk; Sensitivity and Specificity; Triazines/adverse effects; Triazines/therapeutic useMALFORMATIONSeducationPregnancy53business.industryCLUBFOOTCase-control studyOdds ratio228medicine.diseaseConfidence intervalPregnancy ComplicationsPregnancy Trimester FirstPALATECase-Control StudiesREGISTRYNeurology (clinical)business030217 neurology & neurosurgeryNeurology
researchProduct

Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industryCritical IllnessSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Biochemistry (medical)Clinical BiochemistrycoronavirusLipopolysaccharide ReceptorsCOVID-19General Medicinemedicine.disease_causeVirologyPeptide FragmentsCOVID-19 biomarkers coronaviruspresepsinC-Reactive ProteinPooled analysispresepsinHumansMedicinebusinessValue (mathematics)BiomarkersCoronavirusClinical Chemistry and Laboratory Medicine (CCLM)
researchProduct

Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis

2021

BackgroundSmoking has been associated with poorer outcomes in relation to COVID-19. Smokers have higher risk of mortality and have a more severe clinical course. There is paucity of data available on this issue, and a definitive link between smoking and COVID-19 prognosis has yet to be established.MethodsWe included 5224 patients with COVID-19 with an available smoking history in a multicentre international registry Health Outcome Predictive Evaluation for COVID-19 (NCT04334291). Patients were included following an in-hospital admission with a COVID-19 diagnosis. We analysed the outcomes of patients with a current or prior history of smoking compared with the non-smoking group. The primary …

2474medicine.medical_specialtyRC620-627Health (social science)Coronavirus disease 2019 (COVID-19)infectious diseaseMedicine (miscellaneous)Health outcomesSepsis03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpointRisk of mortality1506030212 general & internal medicineNutritional diseases. Deficiency diseasesOriginal Researchpulmonary diseaseNutrition and Dieteticsbusiness.industry2524Clinical courseCOVID-19medicine.diseaseFormer Smoker030228 respiratory systemSmoking statusbusinessBMJ Nutrition, Prevention & Health
researchProduct

Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents

2019

Type 2 diabetes mellitus (T2DM) is an important metabolic disorder for which there is an urgent need for new antidiabetic drugs. α-Glucosidase inhibition is an established protocol for T2DM therapy. Because hyperglycemia causes oxidative tissue damage, the development of agents with both α-glucosidase inhibition and antioxidant activity from natural or natural-derived polyphenols such derivatives of rosmarinic acid (RA) represents an attractive therapeutic option. We report a study on amides 1-10 derived from RA and their evaluation for yeast α-glucosidase inhibition and antioxidant activity (DPPH and ORAC tests). All amides showed higher inhibitory activity than that of RA, were by far mor…

3003DrugAntioxidantDPPHProton Magnetic Resonance Spectroscopymedia_common.quotation_subjectmedicine.medical_treatmentPharmaceutical ScienceOxidative phosphorylationPharmacologyDepsides01 natural sciencesAntioxidantsAnalytical Chemistrychemistry.chemical_compoundDrug DiscoverymedicineHypoglycemic AgentsSettore BIO/15 - Biologia FarmaceuticaCarbon-13 Magnetic Resonance SpectroscopyIC50media_commonAcarbosePharmacology010405 organic chemistrydiabetes mellituDrug Discovery3003 Pharmaceutical ScienceRosmarinic acidOrganic ChemistrySettore CHIM/06 - Chimica OrganicaComplementary and Alternative Medicine2708 DermatologyAmidesamide0104 chemical sciences010404 medicinal & biomolecular chemistryRosmarinic acidComplementary and alternative medicinechemistryCinnamatesPolyphenolAnalytical Chemistry; Molecular Medicine; Pharmacology; 3003; Drug Discovery3003 Pharmaceutical Science; Complementary and Alternative Medicine2708 Dermatology; Organic ChemistryMolecular Medicineα-glucosidasemedicine.drug
researchProduct